GlassScriptPhysician profile
Helen Vickers
NPI 1457439036
$678.07
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $509 · 2024: $58.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $131.50 | 2022 | |
| Abbvie INC. | $130.90 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $64.63 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.49 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $58.90 | 2024 | Ingrezza |
| Lilly USA, LLC | $53.93 | 2022 | |
| Novo Nordisk INC | $29.69 | 2022 | |
| Seqirus USA INC | $25.14 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $21.45 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.90 | 2022 | |
| Eisai INC. | $15.26 | 2021 | |
| Mylan Specialty L.P. | $14.49 | 2022 | |
| Lundbeck LLC | $14.21 | 2021 | |
| Pfizer INC. | $13.73 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.65 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Vickers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.